Vasopressin V2 Receptor Antagonist [EPC]

7766 reported adverse events

Drugs of this class: TOLVAPTAN

These side effects are most commonly reported by patients taking drugs of the Vasopressin V2 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 642
1 DEATH 579
2 CARDIAC FAILURE 530
3 RENAL IMPAIRMENT 437
4 THIRST 309
5 DEHYDRATION 308
6 HEPATIC FUNCTION ABNORMAL 305
7 HYPERNATRAEMIA 296
8 BLOOD SODIUM DECREASED 250
9 PNEUMONIA 245
See all common reactions for Vasopressin V2 Receptor Antagonist [EPC]

Drugs of the Vasopressin V2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RAPID CORRECTION OF HYPONATRAEMIA 189 0.8591
1 PULMONARY VEIN OCCLUSION 8 0.1333
2 RENAL CYST RUPTURED 11 0.1279
3 RENAL CYST HAEMORRHAGE 20 0.1190
4 URINE OSMOLARITY DECREASED 10 0.0990
5 PROCEDURAL FAILURE 7 0.0921
6 LOW CARDIAC OUTPUT SYNDROME 22 0.0917
7 RENAL CYST INFECTION 11 0.0866
8 HYPERNATRAEMIA 296 0.0818
9 HUMAN CHORIONIC GONADOTROPIN POSITIVE 3 0.0789
See all enriched reactions for Vasopressin V2 Receptor Antagonist [EPC]